Latest news with #ExasolAG
Yahoo
2 days ago
- Business
- Yahoo
Strong week for Exasol (ETR:EXL) shareholders doesn't alleviate pain of five-year loss
This week we saw the Exasol AG (ETR:EXL) share price climb by 14%. But that doesn't change the fact that the returns over the last half decade have been stomach churning. Like a ship taking on water, the share price has sunk 79% in that time. The recent bounce might mean the long decline is over, but we are not confident. The fundamental business performance will ultimately determine if the turnaround can be sustained. While the stock has risen 14% in the past week but long term shareholders are still in the red, let's see what the fundamentals can tell us. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During five years of share price growth, Exasol moved from a loss to profitability. Most would consider that to be a good thing, so it's counter-intuitive to see the share price declining. Other metrics may better explain the share price move. Revenue is actually up 10% over the time period. A more detailed examination of the revenue and earnings may or may not explain why the share price languishes; there could be an opportunity. You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image). This free interactive report on Exasol's balance sheet strength is a great place to start, if you want to investigate the stock further. A Different Perspective Exasol provided a TSR of 41% over the year. That's fairly close to the broader market return. The silver lining is that the share price is up in the short term, which flies in the face of the annualised loss of 12% over the last five years. While 'turnarounds seldom turn' there are green shoots for Exasol. Is Exasol cheap compared to other companies? These 3 valuation measures might help you decide. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on German exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
Strong week for Exasol (ETR:EXL) shareholders doesn't alleviate pain of five-year loss
This week we saw the Exasol AG (ETR:EXL) share price climb by 14%. But that doesn't change the fact that the returns over the last half decade have been stomach churning. Like a ship taking on water, the share price has sunk 79% in that time. The recent bounce might mean the long decline is over, but we are not confident. The fundamental business performance will ultimately determine if the turnaround can be sustained. While the stock has risen 14% in the past week but long term shareholders are still in the red, let's see what the fundamentals can tell us. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During five years of share price growth, Exasol moved from a loss to profitability. Most would consider that to be a good thing, so it's counter-intuitive to see the share price declining. Other metrics may better explain the share price move. Revenue is actually up 10% over the time period. A more detailed examination of the revenue and earnings may or may not explain why the share price languishes; there could be an opportunity. You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image). This free interactive report on Exasol's balance sheet strength is a great place to start, if you want to investigate the stock further. A Different Perspective Exasol provided a TSR of 41% over the year. That's fairly close to the broader market return. The silver lining is that the share price is up in the short term, which flies in the face of the annualised loss of 12% over the last five years. While 'turnarounds seldom turn' there are green shoots for Exasol. Is Exasol cheap compared to other companies? These 3 valuation measures might help you decide. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on German exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Associated Press
27-01-2025
- Business
- Associated Press
Exasol AG Strengthens Management Team with Renowned Industry Experts to Accelerate Growth and Market Expansion
NUREMBERG, Germany--(BUSINESS WIRE)--Jan 27, 2025-- Exasol AG (ISIN: DE000A0LR9G9, Xetra: EXL), provider of the world's most powerful analytics engine, has strengthened its management team with Henrik Jorgensen as Chief Revenue Officer (CRO) and Lars Milde as Chief Marketing Officer (CMO). With these strategic appointments and the newly created positions of CRO and CMO, Exasol further grows its management capabilities and, with the additional capacities of renowned industry experts, focuses on accelerating growth and market expansion in the dynamic competitive environment of data analytics. Joerg Tewes, CEO of Exasol AG: 'We are very pleased to strengthen our management team with Henrik Jorgensen and Lars Milde. Their proven track records and extensive expertise will make an important contribution to our mission of providing organizations with the world's most powerful analytics engine. These appointments mark the beginning of an exciting new chapter for Exasol. Henrik Jorgensen and Lars Milde will play key roles in executing our growth strategy. Exasol continues to pursue its vision of helping companies gain better insights faster in a data and AI-driven world. Leading brands such as T-Mobile, Piedmont Healthcare and Helsana already rely on Exasol's powerful analytics engine to drive innovation and growth.' Henrik Jorgensen has been promoted to Chief Revenue Officer (CRO) of Exasol AG after serving as the Company's Senior Vice President of Sales EMEA since December 2023. With a proven track record of scaling businesses for industry leaders such as Quest Software, Tableau Software, and Salesforce, Henrik Jorgensen will now be responsible for global sales and all processes that directly impact revenue at Exasol. He will focus on expanding the customer base, deepening existing customer relationships and accelerating revenue growth in the dynamic data management landscape. Henrik Jorgensen, CRO of Exasol AG: 'In my conversations with customers and prospects, I see a significant shift in the data management landscape. Many companies are opting to keep certain parts of their data on-premises, driven by regulatory requirements, or to avoid the escalating costs associated with high-volume, continuous cloud workloads. This 'cloud smart' approach – a hybrid model that balances on-premises and cloud solutions – is rapidly emerging as a key trend. At Exasol, we are uniquely positioned to provide these forward-thinking companies flexible solutions that enable them to optimize their data infrastructure for both compliance and cost efficiency.' Lars Milde assumes responsibility as Chief Marketing Officer (CMO) for the activities to strengthen Exasol's global positioning. He has more than 25 years of experience in leadership positions at software companies, including IBM, Cognos, Tableau Software, and Salesforce. His expertise in developing brand strategy, demand generation, and customer engagement will be instrumental in strengthening Exasol's market presence. Lars Milde, CMO of Exasol AG: 'I am very excited to join Exasol. The Company is excellently positioned to help customers with data analytics at the conflicting priorities of big data and AI applications on the one hand and exploding cloud costs on the other hand. Exasol's powerful analytics engine enables customers to analyze massive data volumes in a high-frequency manner at an unbeatable price/performance ratio. This capability plays an increasingly critical role in a world of exploding cloud consumption costs.' About Exasol AG Exasol is the world's most powerful analytics engine, purpose-built to handle the toughest data workloads with exceptional scalability and an unmatched price/performance ratio. The Company's highly optimized query engine powers robust data warehouse solutions for both on-premises and hybrid deployments, enabling organizations to achieve superior performance. Exasol empowers data-driven organizations with: Lightning-fast, scalable, and flexible analytics solutions Real-time insights Significant cost reductions Accelerated development Minimal administrative effort For more information about how Exasol can transform your data analytics capabilities, visit Language: English Company: EXASOL AG Neumeyerstraße 22-26 90411 Nuremberg Germany Internet: ISIN: DE000A0LR9G9 WKN: A0LR9G CONTACT: Media Relations Contact: Emily Taylor Director Global Marketing Phone: +49 911 2399 1373 Email: [email protected] Relations Contact: Christoph Marx Head of Investor Relations Phone: +49 911 2399 114 KEYWORD: GERMANY EUROPE SOURCE: Exasol AG Copyright Business Wire 2025. PUB: 01/27/2025 04:14 AM/DISC: 01/27/2025 04:14 AM
